TrialJournal for immunotherapy of cancer2021

Phase Ib study of patients with metastatic castrate-resistant prostate cancer treated with different sequencing regimens of atezolizumab and sipuleucel-T.

Tanya Dorff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.